JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pahlow, B
Right arrow Articles by Davis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pahlow, B
Right arrow Articles by Davis, G.
Journal of the American Osteopathic Association, Vol 91, Issue 1, 51-51
Copyright © 1991 by American Osteopathic Association

Articles

Management of acute paroxysmal supraventricular tachycardia in pregnancy

B Pahlow, AK Geisler, and GH Davis

The treatment of paroxysmal supraventricular tachycardia (PSVT) in pregnancy is not unlike treatment for the general population. The physician should feel confident that the pharmacologic agents ordinarily used to treat this common problem in the general population are safe for both mother and fetus when administered under monitored conditions. In treating paroxysmal supraventricular tachycardia in pregnancy, when both vagal maneuvers and exhaustive medical therapy fail, synchronized, direct-current cardioversion is a safe and effective form of treatment.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Osteopathic Association.